Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
April 13, 2007
By: Tim Wright
CDISC (Clinical Data Interchange Standards Consortium, Inc.) has added two directors to its board, Dr. Christopher Chute of the Mayo Clinical College of Medicine and Paula Brown Stafford of Quintiles Transnational Corp. Dr. Chute and Ms. Stafford bring a wealth of relevant experience to the CDISC board from their respective roles as professor and chair for the biomedical informatics department at the Mayo Clinical College of Medicine, and as executive vice president of global data management at Quintiles. Ms. Stafford brings a global perspective and broad experience from her varied roles within a large CRO. Her current role is heading the globalization of the Quintiles Data Management function, where she leads a team of 1,200 people, representing $100 million investment in revenue. “Paula’s expertise and perspective will be most valuable at this critical point in CDISC’s growth and adoption,” states Rebecca Kush, president of CDISC. Ms. Stafford added, “To date, Quintiles has delivered nearly 200 CDISC-compliant databases on behalf of Pharma. My belief is that the key to the industry’s future is to deliver a CDISC-compliant data structure before the first patient enters a trial. The FDA supports this view and believes that CDISC is the natural leader to make this happen. I am keenly interested in bringing my expertise to the CDISC table and to help lead the vision for the pharmaceutical industry.” Ms. Stafford has accepted the position of chair of the board’s Financial Oversight Committee. She will serve the term through 2007. Dr. Chute has authored numerous peer-reviewed publications regarding standards work in the specific areas of vocabulary and health concept representation in Health Informatics. Dr. Chute has also chaired efforts such as the Joint HL7 and SNOMED Meeting: The Boundary between Vocabulary and Information Models, NASA Vocabulary Summit (2004); ANSI Health Informatics Standards Board (HISB) (2004-2005); NIH Biomedical Computing and Health Informatics: Special Emphasis Panel (2005). Dr. Chute is currently the chair of the U.S. Delegation to the ISO Informatics Technical Committee (2007-2009). Dr. Chute will serve on the board from 2007 through 2009. “CDISC will most certainly benefit from Dr. Chute’s invaluable expertise in the areas of terminology, information technology and standards development,” stated Ms. Kush. The CDISC board has a total of ten directors. Two others were re-elected to serve a second three-year term for 2007-2009. Dr. Pierre-Yves Lastic, senior director, standards management and data privacy at Sanofi-Aventis, and William Rosen, executive director, external affairs, standards and support with Pfizer.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !